Glaxo says Avandia data comforts, experts unsure
565830
Early results from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show any increase in heart attacks among patients, but several experts said the evidence still suggests the popular diabetes drug raises the risk of heart attack.
10518
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription
680034
An executive of the company that makes the diabetes drug Avandia said a researcher who was among the first to link it to heart problems would be held liable for the $4 billion GlaxoSmithKline PLC lost in stock value as a result of his findings, Dr. John B. Buse testified before congressional investigators yesterday.
140789
In the month after a surprising analysis revealed possible heart risks from the blockbuster diabetes drug Avandia, reports of side effects to federal regulators tripled.
434202
A Texas researcher admitted he had leaked a sensitive and controversial report about the heart risks of diabetes drug Avandia to its maker, GlaxoSmithKline, the journal Nature reported on Wednesday.
337275
BusinessWeek Online - The news last week that GlaxoSmithKline&#39;s  popular diabetes drug Avandia may increase the risk of heart attacks is now causing a rift among doctors by specialty, leading to charges by each side that the other is endangering patients. Endocrinologists, who treat diabetics, tend to regard the data, which was published in The New England Journal of Medicine, with skepticism, pointing to weaknesses in the study, particularly when compared to more rigorous clinical trials. Cardiologists and drug safety experts, foremost among them study author Dr. ...
743041
Drugmaker GlaxoSmithKline agreed Thursday to settle charges that it hid and misrepresented unfavorable data about the effectiveness and safety of its top-selling anti
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
85181
A medical researcher who testified at a House hearing about the safety of the popular diabetes drug, Avandia, said he received the veiled threat of a lawsuit by a high-ranking drug company executive.
95097
NEW YORK -- The pharmaceutical industry yesterday said it plans to publish more data about clinical drug trials, despite skepticism about whether the initiative will increase transparency and improve drug safety.
730876
GlaxoSmithKlineâs effort to focus Avandiaâs marketing on African-Americans could backfire as questions arise.
535344
Data on Sanofi-Aventis' experimental bird flu vaccine shows higher doses worked better, but it is unclear whether those results prove the product's effectiveness, U.S. Food and Drug Administration staff said in documents released on Monday.
198445
The global pharmaceutical industry  unveiled plans on Thursday to publish more data about trials of  medicines in a bid to reassure patients following recent alarms  over drug safety.
685237
BRITISH drugs company GlaxoSmithKline has agreed to make public information about its clinical drug trials following accusations it misled doctors about the safety of an anti-depressant for children.
477879
The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies.
65911
WASHINGTON - About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.
439386
The FDA asks for more data about Avastin, which could be used to treat various cancers.